Press "Enter" to skip to content

New patent for Jazz Pharms drug XYREM

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for XYREM
Annual Drug Patent Expirations for XYREM

Xyrem is a drug marketed by Jazz Pharms and is included in one NDA. It is available from three suppliers. There are seven patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for XYREM.

The generic ingredient in XYREM is sodium oxybate. Three suppliers are listed for this compound. Additional details are available on the sodium oxybate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions